Vitiligo is a chronic depigmentation disorder with limited effective treatments, particularly in low-resource settings. Nigella sativa (black cumin) has shown melanogenesis-modulating potential, largely attributed to thymoquinone (TQ). This study investigates the melanogenesis-stimulating activity of 96% ethanol extract of N. sativa (EE BCS), with optimized spectrophotometric detection wavelengths to improve assay precision. Phytochemical screening and HPLC identified flavonoids, saponins, alkaloids, steroids, and a TQ content of 0.04%. B16F10 melanoma cells were assessed for viability (MTT assay), tyrosinase activity (L-DOPA at 490 nm), and melanin content (405 nm). EE BCS showed >90% viability up to 12.50 ppm, with significant increases in tyrosinase activity at 6.25 ppm (143.57%) and 12.50 ppm (224.29%), and melanin content at 3.13 ppm (123.40%), 6.25 ppm (226.30%), and 12.50 ppm (260.50%). Wavelength optimisation enhanced assay specificity, supporting more precise melanogenic assessment. The study demonstrates that EE BCS stimulates melanogenesis in-vitro despite low TQ content, likely due to synergistic phytochemical interactions, making EE BCS a promising candidate for vitiligo therapy. Additionally, the use of compound-specific detection wavelengths (490 nm and 405 nm) enhances assay reliability and highlights the importance of methodological standardization in pigmentation research.
Pratiwi et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: